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Neonatal severe primary hyperparathyroidism (NSPHT) is a rare autosomal recessive disorder of calcium homeostasis. It presents
shortly after birth and is characterized by striking hyperparathyroidism, marked hypercalcemia, and hyperparathyroid bone
disease. It is caused by mutations of the calcium-sensing receptor (CASR), the ionized calcium sensor for the parathyroid cells,
the parafollicular thyroid C cells, and the kidney epithelium, as well as cells in bone and intestine. Without early intervention,
which frequently requires surgical removal of the hyperplastic parathyroids, the patients often succumb to complications of
hypercalcemia and respiratory failure. Finding the parathyroid gland in small neonates is not an easy task. Here we report on
a patient with neonatal hyperparathyroidism who was treated by total parathyroidectomy and discuss the various ways of helping
to ﬁnd the parathyroid glands during surgery at this young age.
1.CaseReport
The patient is a 3.2Kg female the product of uneventful 38-
week gestation. The parents are ﬁrst cousins from Sri Lanka
and were unaware of any similar cases in their extended fam-
ily. APGAR scores were 8 and 9 at 1 and 5min, respectively.
T h en e w b o r nw a sw e l lf o rt h eﬁ r s tf e wd a y so fl i f e ,b u to n
the 7th day of life, she became progressively more hypoactive
and fed poorly. She was transferred to a pediatric intensive
care unit with a presumptive diagnosis of neonatal sepsis.
On physical examination the weight was 2.2Kg, with
a loss of 1Kg since birth. The infant was hypoactive and
dehydrated. Blood pressure was 85/55mmHg, with general-
ized hypotonia. Biochemical analysis showed hypercalcemia
(corrected calcium, 4mmol/L (normal <2.73mmol/L); total
calcium, 6mmol/L). Ionized serum calcium ranged between
1.85 and 2.05mmol/L (normal <1.23mmol/L), and serum
phosphate was as low at 0.42mmol/L (normal >1.45mmol/
L). Serum alkaline phosphatase activity was high (518IU/L;
normal <420IU/L). Both serum creatinine and urea
were high at 133umol/L (35:53umol/L0) and 38mmol/L
(1.4:5mmol/L), respectively. Serum electrolytes (sodium
160mmol/L; potassium 3.0mmol/L; chloride 126mmol/L;
and bicarbonate 21mmol/L), all compatible with dehydra-
tion and prerenal failure.
The clinical diagnosis of NSHPT was based on the early
onset, life-threatening hypercalcemia, and the radiologic
evidence of hyperparathyroidism. On the second day of
admission, the parathyroid hormone level was 573ng/L
(normal, 15–65ng/L). The urine calcium/creatinine index
(both measured in millimoles) was 8.3 (normal <0.4). The
serum 25-hydroxycholecalciferol was 23nmol/L (normal
values 75–200nmol/L). Skeletal survey revealed generalized
skeletal undermineralization, with evidence of subperiosteal
bone resorption. Metaphyses of the long bones showed
marked destruction with cupping and fraying and a meta-
physealfractureoftheleftfemurwasobserved.Themandible
and skull were normal.
The patient’s hypercalcemia was managed initially with
hyperhydration, furosemide, and calcitonin with minimal
eﬀect. She also received maintenance dose of 400IU/day of
vitamin D3. On day 2, intravenous pamidronate treatment
(20mg/m2, equivalent 3mg) was started, without evidence
of adverse reaction. In particular, there was no hypomagne-
semia, vomiting, or respiratory distress, and no evidence for
lymphocytopenia or a febrile reaction. The corrected serum2 ISRN Pediatrics
calcium dropped to a minimum of 3.18mmol/L, but the
PTH level increased to 1,900ng/L.
An ultrasound of the neck failed to demonstrate enlarged
parathyroid glands, and renal ultrasound showed no evi-
dence of renal stones or nephrocalcinosis. Sestamibi scintig-
raphy showed no evidence of ectopic parathyroid tissue.
At age 10 days, the infant underwent exploratory surgery
of the neck. Intraoperatively, 0.1mg/kg of methylene blue
was given very slowly intravenously to help in localizing the
parathyroid glands. The parathyroid glands although very
tiny at this age, but taken the methylene blue rendering
them relatively easy to indentify. Two parathyroid glands
were located on the left side, but on the right side, only
the upper parathyroid could be identiﬁed. A piece of
tissue considered as possibly right lower parathyroid was
negative on subsequent histopathologic analysis. The three
excised parathyroid were conﬁrmed histologically to be
hyperplastic parathyroid glands. On eﬀect, we were left
with remaining right lower parathyroid gland unaccounted
for.
During surgery and immediately after, the serum PTH
dropped rapidly from a preoperative high of 1,383ng/L
to 791, 395, 324, and 310ng/L at hourly intervals after
removal of the glands. Postoperatively, serum PTH levels
were 426, 432, and 452ng/L, respectively, at weekly intervals.
By day 3 post-op, the patient developed transient asymp-
tomatic hypocalcemia (corrected calcium was 1.8mmol/L
and phosphate was 1.0mmol/L) despite a PTH level of
426ng/L. Treatment with oral alphacalcidiol (0.1ug/kg/day)
and calcium (40mg/kg/day elemental Ca) was started. Three
weeks and 3 months postoperatively, the calcium/urine ratio
dropped to 0.2 then it became 0.16, respectively.
Two and half months later, hyperparathyroidism (PTH =
305ng/L) and hypercalcemia (total calcium = 4.0mmol/L)
had recurred, although the 25(OH) D had increased to
80nmol/L (normal, 75–200nmol/L).
At the age of 3 months, it was decided to reexplore the
neck to identify the fourth parathyroid gland. No imaging
was done in view of the failure of this imaging to be helpful
before the ﬁrst operation. At re-operation, we looked for
this gland at all the possible sites but could not ﬁnd this
missing gland. As we are aware that a parathyroid could be
intrathymic or even intrathyroid so it was decided to do
empiric thymectomy and right hemithroidectomy, as it is
the side where this missing parathyroid is sited. Fortunately,
histopathologic examination of the right hemithyroid
revealed an intrathyroid parathyroid gland.
TheserumPTHdroppedfrom407ng/Lpreoperativelyto
6ng/L and 3ng/L on days 1 and 3 after surgery, respectively.
The calcium level (4mmol/L preoperatively) normalized to
2.3mmol/L within a day after surgery.
Oral calcium (30mg/kg/d of elemental Ca every 6h) and
1 alpha calcidiol (0.25µg daily) were started. The serum
levels of free thyroxine (fT4) were 18, 14, 16, 17pmol/L
(10.23–23.17pmol/L) and thyroid-stimulating hormone lev-
els were 1.18, 6, 8, and 4.6mU/L (0.3–5mIU/L) at day 1,
month 1, month 3, and month 5, respectively, after surgery.
A repeat skeletal survey 3 months after ﬁnal surgery showed
increased bone density, healing of the metaphyseal fracture,
and resolution of the subperiosteal resorption. Two months
after surgery, the patient had asymptomatic hypocalcemia
(total calcium: 1.2mmol/L) during a clinic visit. She was
maintained on oral elemental calcium (100mg/kg/d) and
alphacalcidiol(0.2µg/kg/d)inordertocorrecthypocalcemia.
Her serum magnesium was 0.65mmol/L (normal, 0.65–
1.0mmol/L). No thyroid dysfunction was detected postsur-
gically. She did not have any hypocalcemia afterwards and
phosphorus level after 2 years was 2.58mg/dL.
2. Discussion
NSHPT can present at any time within the ﬁrst 6 months
of life, but is often discovered in the ﬁrst few weeks
postnatally. Aﬀected infants have severe, symptomatic, PTH-
dependent hypercalcemia, along with the bony changes of
severe hyperparathyroidism. They often exhibit polyuria,
dehydration, and hypotonia associated with a history of
failure to thrive. Early diagnosis is critical as untreated
NSHPT can have a devastating neurodevelopmental eﬀects.
Although some patients have been treated with acute
medical management and subtotal parathyroidectomy, total
parathyroidectomy with or without autotransplantation is
the recommended line of management at the moment.
The surgical management of neonatal hyperparathy-
roidism was ﬁrst reported in 1964, and the urgency of
doing this was recognized shortly after. Initially, subtotal
parathyroidectomy was the procedure of choice, but owing
to a signiﬁcant rate of recurrence, total parathyroidectomy
was adopted. Total parathyroidectomy proved to be eﬀective
in controlling the disease with minimal morbidity, but
lifelong calcium and vitamin D supplements were required.
Following the experience with adult hyperparathyroidism,
reports of total parathyroidectomy with heterotopic auto-
transplantationappearedintheliterature.Thisistoavoidthe
lifelongreplacementtherapy.Followingautotransplantation,
a failure rate of 6% has been reported, and 33% are expected
to have graft-dependent hypercalcemia.
There are diﬀerent modalities that have been used to
localize the hyperfunctioning parathyroid glands (Table 1).
While there are known diagnostic means in adults that
help localize the parathyroid adenomas or hyperplastic
glands before surgery, for example, the combination of
99mTc-sestamibi/99mTc-pertechnetate subtraction scintig-
raphy (SS) and high-resolution neck ultrasonography (US),
this was found not to be true in children.
Al-Shanafey et al. [2] showed that preoperative localiza-
tionstudiesarenothelpful.Thiswasrecommendedbyothers
too.
In the adult patients it is not always easy to ﬁnd the
four parathyroid glands during surgery. This is because of
the variable locations and the small size of these glands. The
parathyroid glands are the most inconsistent, in location,
among all the endocrine glands in humans. So, knowledge
of the possible locations of these glands is essential before
embarking on performing parathyroidectomy.
The parathyroid glands, typically four in number,
develop from the dorsal extremities of the third and fourth
pharyngeal (branchial) pouches and are sometimes thereforeISRN Pediatrics 3
Table 1: Parathyroid gland localization modalities.
Non invasive preoperative
(i) Ultrasound
(ii) MRI
(iii) CT
(iv) Thallium-technetium scintigraphy
(v) Technetium-99 Sestamibi scintigraphy
(vi) Radioiodine or technetium thyroid scan
Invasive preoperative
(i) Selective arteriography or digital subtraction
(ii) angiography
(iii) Selective venous sampling
(iv) Fine-needle aspiration
Intraoperative
(i) Ultrasonography
(ii) Methylene blue injection
(iii) Quick parathyroid hormone measurements
designated as parathyroid glands III and parathyroid glands
IV. In the course of their development, the parathyroids
derived from the third pouches soon become associated with
the thymus, which develops primarily from these pouches,
while those from the fourth pouches become associated with
the developing thyroid gland.
Asthethyroidandthymus,withtheirassociatedparathy-
roid glands, move caudally from the region in which
they originate, the thymus normally descends beyond the
level at which the thyroid halts. The parathyroids derived
from the third branchial pouches are therefore typically
carried father than those derived from the fourth branchial
pouches. Thus the parathyroids from the fourth pouches
are typically located more cranially on the thyroid gland
and are called superior parathyroid glands, while those
derived from the third pouches are typically freed from
the thymus and become associated with the thyroid gland
toward its lower pole, becoming the inferior parathyroid
glands.
The superior parathyroid tends to be less variable than
the inferior glands and they are generally found in the pos-
terior surface of the thyroid gland. The lower parathyroids
have a longer and more complex journey to reach their ﬁnal
destination caudal to the superior ones and can have more
variable sites. Parathyroids can be found also anywhere along
the tracheoesophageal groove (Figure 1).
Beside these various sites, parathyroid are also known
to exist in some rare sites, for example, the thymus or
intrathyroid.Knowledgeofthisfactguidedusduringsurgery
on the course to take. To identify the glands during surgery,
Kuriloﬀand sanborn 2004 [3] found that intraoperative
methylene blue infusion to be safe and eﬀective in rapid
identiﬁcation of parathyroid tissue.
1%
1%
10%
12%
20%
18%
5%
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Figure 1: Anatomic locations of abnormal parathyroid glands
found at reoperation by single group [1].
On conclusion neonatal hyperparathyroidism is a rare
congenital anomaly which is life threatening. Bilateral surgi-
cal exploration is the deﬁnitive mode for their detection and
removal. Intraoperative methylene blue infusion is helpful in
localizing the parathyroid glands. These glands could exist in
some rare sites, for example, the thymus or intrathyroid.
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